Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pterostilbene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103102254B details a high-yield Pterostilbene synthesis. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Novel synthesis route for Pterostilbene via aldol condensation and diazotization. Offers high purity and cost efficiency for pharmaceutical intermediates manufacturing.
Patent CN117586206B reveals novel antitumor synthesis. High-purity intermediates with scalable routes for cost reduction and supply chain reliability.
Patent CN118271191A details a novel synthesis route for Pterostilbene derivatives with potent COX-2 inhibition, offering significant supply chain and cost advantages for API manufacturing.
Novel copper-catalyzed decarboxylation route for high-purity resveratrol and pterostilbene intermediates. Reduces steps and eliminates protection groups for cost-effective manufacturing.
Novel Pd-Cu catalytic method enhances pterostilbene production efficiency. Reduces steps and improves scalability for reliable pharmaceutical intermediate supplier partnerships.
Patent CN1301246C details novel 1-cyano-1-(3,5-dimethoxyphenyl)-2-phenylethylene synthesis. Offers superior antitumor potential and scalable manufacturing for reliable pharmaceutical intermediate suppliers.
Novel synthesis method for Pterostilbene phosphate disodium salt. High yield, mild conditions, scalable production for pharmaceutical applications.